Holen Sie sich die Stockscreener-App
10.30
0.05%
0.005
Handel nachbörslich:
10.29
-0.01
-0.10%
Schlusskurs vom Vortag:
$10.29
Offen:
$10.28
24-Stunden-Volumen:
52,504
Relative Volume:
1.32
Marktkapitalisierung:
$345.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.03%
1M Leistung:
+0.00%
6M Leistung:
+2.64%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.28
$10.31
1-Wochen-Bereich:
$10.26
$10.34
52-Wochen-Spanne:
$9.96
$10.34
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Firmenname
Drugs Made In America Acquisition Corp
Sektor
Branche
Telefon
954-870-3104
Adresse
2 PELICAN DR., FORT LAUDERDALE
Vergleichen Sie DMAA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.30 | 345.06M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.10 | 1.76B | 3.13B | -174.20M | -111.20M | -0.6688 |
|
CCCX
Churchill Capital Corp X
|
24.33 | 1.17B | 0 | 0 | 0 | 0.00 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
9.97 | 589.93M | 0 | 0 | 0 | 0.00 |
|
HOND
Hcm Ii Acquisition Corp
|
24.97 | 603.75M | 0 | 0 | 0 | 0.00 |
|
AEXA
American Exceptionalism Acquisition Corp A
|
11.65 | 559.40M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Aktie (DMAA) Neueste Nachrichten
How Drugs Made In America Acquisition Corp. stock valuations compare to rivalsEarnings Performance Report & AI Powered Market Entry Strategies - newser.com
Using data models to predict Drugs Made In America Acquisition Corp. stock movement2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com
Why analysts upgrade Drugs Made In America Acquisition Corp. stockTrade Signal Summary & Real-Time Volume Triggers - newser.com
What technical models suggest about Drugs Made In America Acquisition Corp. Equity Right’s comeback2025 AllTime Highs & High Accuracy Swing Trade Signals - newser.com
How to read the order book for Drugs Made In America Acquisition Corp.July 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
Chart based exit strategy for Drugs Made In America Acquisition Corp.July 2025 Trade Ideas & Stock Timing and Entry Methods - newser.com
Top chart patterns to watch in Drugs Made In America Acquisition Corp.Trade Performance Summary & Long-Term Capital Growth Ideas - newser.com
Ranking Drugs Made In America Acquisition Corp. among high performing stocks via toolsBreakout Watch & Safe Swing Trade Setups - newser.com
Can swing trading help recover from Drugs Made In America Acquisition Corp. lossesOil Prices & High Conviction Buy Zone Alerts - newser.com
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Britannica
How to interpret RSI for Drugs Made In America Acquisition Corp. stockJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Does Drugs Made In America Acquisition Corp. stock trade at a discount to peersShort Setup & Daily Risk Controlled Trade Plans - newser.com
What’s next for Drugs Made In America Acquisition Corp. stock priceQuarterly Portfolio Report & Consistent Growth Stock Picks - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for Drugs Made In America Acquisition (NASDAQ:DMAA) - MarketBeat
Drugs Made In America Acquisition Corp Equity Right Stock Analysis and ForecastDividend Yield Trends & Free Expert Guidance For Growth - earlytimes.in
Analyzing Drugs Made In America Acquisition Corp. Equity Right with multi timeframe charts2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Published on: 2025-10-09 03:21:12 - newser.com
Why Drugs Made In America Acquisition Corp. Equity Right is moving todayTrade Exit Summary & Consistent Return Investment Signals - newser.com
Families of Trump and commerce secretary stand to benefit from U.S. drug overhaul: WSJ - Seeking Alpha
Trump Wants to Overhaul Drug Sales. A Company Tied to His Son Stands to Benefit. - The Wall Street Journal
Regression analysis insights on Drugs Made In America Acquisition Corp. performance2025 Major Catalysts & Accurate Technical Buy Alerts - newser.com
Key metrics from Drugs Made In America Acquisition Corp.’s quarterly data2025 Performance Recap & AI Driven Stock Reports - newser.com
Will Drugs Made In America Acquisition Corp. stock go up soonCPI Data & Weekly Breakout Stock Alerts - newser.com
Canadian tech helped U.S. strike alleged Venezuelan drug boats: report - CBC
Should you wait for a breakout in Drugs Made In America Acquisition Corp. Equity RightJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
Why Drugs Made In America Acquisition Corp. stock remains undervalued2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
Is Drugs Made In America Acquisition Corp. stock bottoming outMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Should You Watch Oil and Natural Gas Corporation Limited for Sector Rotation UpsideStock Buy Signals & Reinvest for Maximum Compounding Returns - earlytimes.in
Tick level data insight on Drugs Made In America Acquisition Corp. Equity Right volatilityJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-03 05:28:21 - newser.com
Will Drugs Made In America Acquisition Corp. Equity Right stock attract ESG investorsStock Surge & Momentum Based Trading Signals - newser.com
Drugs Made In America Acquisition II Corp. completes $500 million IPO and private placement - Investing.com
What analysts say about Drugs Made In America Acquisition Corp stockTechnical Pattern Recognition & These 3 Stocks Could Change Your Portfolio - earlytimes.in
PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 b - The Economic Times
Finanzdaten der Drugs Made In America Acquisition Corp-Aktie (DMAA)
Es liegen keine Finanzdaten für Drugs Made In America Acquisition Corp (DMAA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):